helen naylor
Last active: 4/17/2019

When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data.

Pulley JM, Jerome RN, Zaleski NM, Shirey-Rice JK, Pruijssers AJ, Lavieri RR, Chettiar SN, Naylor HM, Aronoff DM, Edwards DA, Niswender CM, Dugan LL, Crofford LJ, Bernard GR, Holroyd KJ
Assay Drug Dev Technol. 2017 15 (8): 354-361

PMID: 29193979 · PMCID: PMC5731541 · DOI:10.1089/adt.2017.821

MeSH Terms (7)

Animals Clinical Trials as Topic Decision Making Drug Evaluation, Preclinical Drug Repositioning Humans Models, Animal

Connections (4)

This publication is referenced by other Labnodes entities:

Links